1-4 of 4
Thérèse Gargi
Close
Sort by
Journal Articles

Prognostic Value of 18F-FDG Positron Emission Tomography Used for Assessment of the First Line Therapy in 410 Diffuse Large B-Cell Lymphoma Patients: A Daily Practice Evaluation Before and After the Prescription of This Metabolic Imaging Technique,

Herve Ghesquieres, MD, PhD, Céline Ferlay, Emilie Lavergne, Emmanuelle Nicolas Virelizier, MD, Izabela-Irina Domnisoru, MD, Philippe Rey, MD, Thérèse Gargi, Sylvie Chabaud, MD, Catherine Chassagne-Clément, MD, Bertrand Favier, PhD, Pierre Biron, MD, Thomas Mognetti, MD, Vanina Isnardi, MD, Catherine Sebban, MD, Jean-Yves Blay, MD, PhD, Sébastien Cimarelli, MD
Journal: Blood
Blood (2011) 118 (21): 3686.
https://doi.org/10.1182/blood.V118.21.3686.3686
Published: 2011
Journal Articles

Evaluation in the Context of Daily Practice of Follicular Lymphoma patients' Outcome Before and After Approval of Rituximab in First Line Therapy in This Indication: Results of a Retrospective Analysis of 247 Unselected Patients with a 5-Year Median of Follow-up,

Emmanuelle Nicolas Virelizier, MD, Celine Segura-Ferlay, Izabela-Irina Domnisoru, MD, Philippe Rey, MD, Thérèse Gargi, Catherine Chassagne-Clément, MD, Bertrand Favier, PhD, Pierre Biron, MD, Amine Belhabri, MD, Catherine Sebban, MD, Jean-Yves Blay, MD, PhD, Herve Ghesquieres, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3698.
https://doi.org/10.1182/blood.V118.21.3698.3698
Published: 2011
Journal Articles

Lymphopenia Prior High-Dose Chemotherapy Is a Major Prognostic Factor for Severe Infectious Complication after Autologous Blood Stem Cell Transplantation for Lymphoma’s Patients.

Hervé Ghesquières, MD, Roch Houot, MD, Céline Ferlay, Catherine Sebban, MD, Thérèse Gargi, CRA, Irène Philip, MD, Pierre Biron, MD, Isabelle Ray-Coquard, MD, Jean-Yves Blay, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2984.
https://doi.org/10.1182/blood.V108.11.2984.2984
Published: 2006
Journal Articles

Comparison of Outcome of Unselected Patients with Diffuse Large B-Cell Lymphoma Diagnosed before and after Approval of Rituximab in France in This Indication.

Hervé Ghesquières, MD, Catherine Sebban, MD, Catherine Chassagne, MD, Liana Carausu, MD, Thérèse Gargi, CRA, Bertrand Favier, PhD, Irène Philip, MD, Jean Yves Blay, MD, PhD, Pierre Biron, MD
Journal: Blood
Blood (2005) 106 (11): 4766.
https://doi.org/10.1182/blood.V106.11.4766.4766
Published: 2005